140 related articles for article (PubMed ID: 10668412)
1. A double-blind, placebo-controlled study of the safety, tolerability and pharmacokinetics of CP-101,606 in patients with a mild or moderate traumatic brain injury.
Merchant RE; Bullock MR; Carmack CA; Shah AK; Wilner KD; Ko G; Williams SA
Ann N Y Acad Sci; 1999; 890():42-50. PubMed ID: 10668412
[TBL] [Abstract][Full Text] [Related]
2. An open-label study of CP-101,606 in subjects with a severe traumatic head injury or spontaneous intracerebral hemorrhage.
Bullock MR; Merchant RE; Carmack CA; Doppenberg E; Shah AK; Wilner KD; Ko G; Williams SA
Ann N Y Acad Sci; 1999; 890():51-8. PubMed ID: 10668413
[TBL] [Abstract][Full Text] [Related]
3. The effect of the selective NMDA receptor antagonist traxoprodil in the treatment of traumatic brain injury.
Yurkewicz L; Weaver J; Bullock MR; Marshall LF
J Neurotrauma; 2005 Dec; 22(12):1428-43. PubMed ID: 16379581
[TBL] [Abstract][Full Text] [Related]
4. Treatment of acute ischaemic stroke with the low-affinity, use-dependent NMDA antagonist AR-R15896AR. A safety and tolerability study.
Diener HC; AlKhedr A; Busse O; Hacke W; Zingmark PH; Jonsson N; Basun H;
J Neurol; 2002 May; 249(5):561-8. PubMed ID: 12021946
[TBL] [Abstract][Full Text] [Related]
5. Tolerability of the low-affinity, use-dependent NMDA antagonist AR-R15896AR in stroke patients: a dose-ranging study.
Lees KR; Dyker AG; Sharma A; Ford GA; Ardron ME; Grosset DG
Stroke; 2001 Feb; 32(2):466-72. PubMed ID: 11157184
[TBL] [Abstract][Full Text] [Related]
6. Effects of the bradykinin antagonist Bradycor (deltibant, CP-1027) in severe traumatic brain injury: results of a multi-center, randomized, placebo-controlled trial. American Brain Injury Consortium Study Group.
Marmarou A; Nichols J; Burgess J; Newell D; Troha J; Burnham D; Pitts L
J Neurotrauma; 1999 Jun; 16(6):431-44. PubMed ID: 10391361
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effect of gacyclidine. A multicenter double-blind pilot trial in patients with acute traumatic brain injury.
Lepeintre JF; D'Arbigny P; Mathé JF; Vigué B; Loubert G; Delcour J; Kempf C; Tadié M
Neurochirurgie; 2004 Jun; 50(2-3 Pt 1):83-95. PubMed ID: 15213636
[TBL] [Abstract][Full Text] [Related]
8. Amantadine to improve neurorecovery in traumatic brain injury-associated diffuse axonal injury: a pilot double-blind randomized trial.
Meythaler JM; Brunner RC; Johnson A; Novack TA
J Head Trauma Rehabil; 2002 Aug; 17(4):300-13. PubMed ID: 12105999
[TBL] [Abstract][Full Text] [Related]
9. Very early administration of progesterone for acute traumatic brain injury.
Wright DW; Yeatts SD; Silbergleit R; Palesch YY; Hertzberg VS; Frankel M; Goldstein FC; Caveney AF; Howlett-Smith H; Bengelink EM; Manley GT; Merck LH; Janis LS; Barsan WG;
N Engl J Med; 2014 Dec; 371(26):2457-66. PubMed ID: 25493974
[TBL] [Abstract][Full Text] [Related]
10. Dosing and safety of cyclosporine in patients with severe brain injury.
Hatton J; Rosbolt B; Empey P; Kryscio R; Young B
J Neurosurg; 2008 Oct; 109(4):699-707. PubMed ID: 18826358
[TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blinded, placebo-controlled pilot trial of anticoagulation in low-risk traumatic brain injury: The Delayed Versus Early Enoxaparin Prophylaxis I (DEEP I) study.
Phelan HA; Wolf SE; Norwood SH; Aldy K; Brakenridge SC; Eastman AL; Madden CJ; Nakonezny PA; Yang L; Chason DP; Arbique GM; Berne J; Minei JP
J Trauma Acute Care Surg; 2012 Dec; 73(6):1434-41. PubMed ID: 22914079
[TBL] [Abstract][Full Text] [Related]
12. Mitoxantrone: a review of its use in multiple sclerosis.
Scott LJ; Figgitt DP
CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
[TBL] [Abstract][Full Text] [Related]
13. A single dose, three-arm, placebo-controlled, phase I study of the bradykinin B2 receptor antagonist Anatibant (LF16-0687Ms) in patients with severe traumatic brain injury.
Marmarou A; Guy M; Murphey L; Roy F; Layani L; Combal JP; Marquer C;
J Neurotrauma; 2005 Dec; 22(12):1444-55. PubMed ID: 16379582
[TBL] [Abstract][Full Text] [Related]
14. Systemic metabolic effects of combined insulin-like growth factor-I and growth hormone therapy in patients who have sustained acute traumatic brain injury.
Hatton J; Kryscio R; Ryan M; Ott L; Young B
J Neurosurg; 2006 Dec; 105(6):843-52. PubMed ID: 17405254
[TBL] [Abstract][Full Text] [Related]
15. Novel approach to the role of NMDA receptors in traumatic brain injury.
Shohami E; Biegon A
CNS Neurol Disord Drug Targets; 2014; 13(4):567-73. PubMed ID: 24168367
[TBL] [Abstract][Full Text] [Related]
16. Effects of the NMDA antagonist CP-98,113 on regional cerebral edema and cardiovascular, cognitive, and neurobehavioral function following experimental brain injury in the rat.
Okiyama K; Smith DH; White WF; McIntosh TK
Brain Res; 1998 May; 792(2):291-8. PubMed ID: 9593949
[TBL] [Abstract][Full Text] [Related]
17. Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT).
Zafonte RD; Bagiella E; Ansel BM; Novack TA; Friedewald WT; Hesdorffer DC; Timmons SD; Jallo J; Eisenberg H; Hart T; Ricker JH; Diaz-Arrastia R; Merchant RE; Temkin NR; Melton S; Dikmen SS
JAMA; 2012 Nov; 308(19):1993-2000. PubMed ID: 23168823
[TBL] [Abstract][Full Text] [Related]
18. Dose escalation study of the NMDA glycine-site antagonist licostinel in acute ischemic stroke.
Albers GW; Clark WM; Atkinson RP; Madden K; Data JL; Whitehouse MJ
Stroke; 1999 Mar; 30(3):508-13. PubMed ID: 10066844
[TBL] [Abstract][Full Text] [Related]
19. Safety and tolerability of the glutamate antagonist CGS 19755 (Selfotel) in patients with acute ischemic stroke. Results of a phase IIa randomized trial.
Grotta J; Clark W; Coull B; Pettigrew LC; Mackay B; Goldstein LB; Meissner I; Murphy D; LaRue L
Stroke; 1995 Apr; 26(4):602-5. PubMed ID: 7709405
[TBL] [Abstract][Full Text] [Related]
20. Effects of the novel NMDA antagonists CP-98,113, CP-101,581 and CP-101,606 on cognitive function and regional cerebral edema following experimental brain injury in the rat.
Okiyama K; Smith DH; White WF; Richter K; McIntosh TK
J Neurotrauma; 1997 Apr; 14(4):211-22. PubMed ID: 9151770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
